MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways
Authors: Jie Ding
Changyan Liang
Liuzhi Deng
Xiaomao Li
Yuebo Yang
Journal: Oncology Reports (2017)
Discipline: CLINICAL MEDICINE
Keywords: Cervical cancer; microRNAs; miR-433; tumour suppressors; promoters
Affiliations: Department of Gynecology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, P.R. China.

Abstract:  Cervical cancer is one of the most common female malignancies worldwide. Emerging data have shown that microRNAs (miRNAs) play significant roles in various human cancers, including cervical cancer. Aberrantly expressed miRNAs in cervical cancer contribute to tumour occurrence and development as either tumour suppressors or promoters. Research suggests that miRNA-433 (miR-433) possibly plays an important role in the development of various cancer types. However, no study has explored the expression patterns, roles and underlying mechanisms of miR-433 in cervical cancer. In the present study, we demonstrated significant downregulation of miR-433 in cervical cancer tissues and cell lines. Low miR-433 expression was found to significantly correlate with patient characteristics including tumour size, International Federation of Gynecology and Obstetrics stage, lymph node and distant metastases. Functional studies showed that restoration of miR-433 inhibited cell proliferation and invasion and increased apoptosis in cervical cancer cells. Metadherin (MTDH) was also validated as a direct target gene of miR-433. MTDH mRNA expression was upregulated in cervical cancer tissues and was inversely correlated with miR-433 expression. MTDH knockdown showed similar tumour-suppressive roles as miR-433 overexpression in regards to cervical cancer cell proliferation, invasion and apoptosis. Rescue experiments revealed that MTDH overexpression markedly reversed the effects of miR-433 overexpression in regards to proliferation, invasion and apoptosis of cervical cancer cells. Further investigations revealed that miR-433 inactivated AKT and β-catenin pathways in cervical cancer. Collectively, these findings indicate the essential roles of miR-433 in suppressing cervical cancer progression and suggest its potential as a therapeutic target for the treatment of cervical cancer. 

Retracted: No

PubPeer comments:
 This is a SciGen paper (i.e., computer-generated nonsense) accepted in ACM-published proceedings. This is overwhelmingly clear from the vocabulary and the style of this paper. Can the person who submitted this give a comment? ![file] ![file] ![file] , 
 ACM is investigating... ![file] --- ![file] , 
 Retracted September 15, 2021. --- NOTICE OF RETRACTION: It has been determined that the author of this Work submitted a computer-generated paper. As a result, ACM has retracted this paper from the ACM Digital Library as it violates the ACM Policy on Plagiarism, Misrepresentation, and Falsification. As from the date of retraction, September 15, 2021, this paper should no longer be cited as a publication in the literature and the author has been advised to no longer list this Work as a published paper in their official list of publications. , 
 The entire conference proceedings are now a matter of concern: NOTICE OF CONCERN: In the process of investigating potential publication-related misconduct in connection with an individual paper published in the IHIP 2018 Conference Proceedings, which resulted in the Retraction of that individual paper, serious concerns have been raised that cast doubt on the integrity of the peer review process related to the IHIP 2018 Conference and all papers published in the Proceedings of this Conference. As a result, ACM is issuing a formal Notice of Concern for all papers published in this Proceedings while a thorough investigation takes place and strongly suggests that this paper not be cited in the literature until ACM?s investigation has concluded and final decisions have been made regarding the integrity of the peer review process for this Conference. ,